Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |